| SpectraBase Spectrum ID |
2mkNl3uCDFg |
| Name |
N-[1-(2,3-Dimethyl-4-methoxyphenyl)propan-2-yl]-4-propylbenzamide |
| Classification |
Amphetamine analog designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
339.219829176 u |
| Formula |
C22H29NO2 |
| InChI |
InChI=1S/C22H29NO2/c1-6-7-18-8-10-19(11-9-18)22(24)23-15(2)14-20-12-13-21(25-5)17(4)16(20)3/h8-13,15H,6-7,14H2,1-5H3,(H,23,24) |
| InChIKey |
LKQYVEVOQRONMY-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
339.479 g/mol |
| Nominal Mass |
339 u |
| Quality |
792 |
| Retention Index |
2564 |
| SMILES |
C=1(C(=C(C(=CC1)OC)C)C)CC(NC(C=1C=CC(=CC1)CCC)=O)C |
| SPLASH |
splash10-002b-1900000000-64f415a0ff7212bddcc0 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-[1-(4-Methoxy-2,3-dimethylphenyl)propan-2-yl]-4-propylbenzamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_030248 |
![N-[1-(2,3-Dimethyl-4-methoxyphenyl)propan-2-yl]-4-propylbenzamide](/api/spectrum/2mkNl3uCDFg/structure.png?h=300&w=458 "N-[1-(2,3-Dimethyl-4-methoxyphenyl)propan-2-yl]-4-propylbenzamide")
